MedPath
HSA Product

KABIVEN PERIPHERAL EMULSION FOR INFUSION

Product approved by Health Sciences Authority (SG)

Basic Information

KABIVEN PERIPHERAL EMULSION FOR INFUSION

INJECTION

Regulatory Information

SIN11718P

November 16, 2001

General Sale List

Therapeutic

INTRAVENOUS

August 10, 2023

June 3, 2025

XB05BA10

Company Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Active Ingredients

L-TRYPTOPHAN

Strength: 0.4 g/l

L-GLUTAMIC ACID

Strength: 1.2 g/l

L-LYSINE HCl EQV L-LYSINE

Strength: 1.9 g/l

L-VALINE

Strength: 1.5 g/l

L-PHENYLALANINE

Strength: 1.6 g/l

L-TYROSINE

Strength: 0.05 g/l

L-SERINE

Strength: 0.94 g/l

POTASSIUM CHLORIDE

Strength: 1.2 g/l

L-METHIONINE

Strength: 1.2 g/l

L-ISOLEUCINE

Strength: 1.2 g/l

SOYABEAN OIL

Strength: 35.0 g/l

L-ASPARTIC ACID

Strength: 0.71 g/l

L-ALANINE

Strength: 3.3 g/l

L-LEUCINE

Strength: 1.6 g/l

L-ARGININE

Strength: 2.4 g/l

L-PROLINE

Strength: 1.4 g/l

L-HISTIDINE

Strength: 1.4 g/l

L-THREONINE

Strength: 1.2 g/l

SODIUM ACETATE TRIHYDRATE

Strength: 1.7 g/l

© Copyright 2025. All Rights Reserved by MedPath